|
US7329725B1
(en)
*
|
2003-10-29 |
2008-02-12 |
Nastech Pharmaceutical Company Inc. |
Phage displayed Trp cage ligands
|
|
CA2572961C
(en)
|
2004-07-06 |
2016-08-16 |
Bioren, Inc. |
Universal antibody libraries
|
|
CA2573259A1
(en)
*
|
2004-07-06 |
2006-02-09 |
Bioren Inc. |
High affinity anti-tnf-alpha antibodies and method
|
|
JP4939410B2
(ja)
|
2004-07-06 |
2012-05-23 |
バイオレン，インク． |
強化された特性を持つ変性ポリペプチドを発生させるためのルックスルー変異誘発
|
|
WO2006094234A1
(en)
*
|
2005-03-03 |
2006-09-08 |
Xencor, Inc. |
Methods for the design of libraries of protein variants
|
|
US20080207467A1
(en)
*
|
2005-03-03 |
2008-08-28 |
Xencor, Inc. |
Methods for the design of libraries of protein variants
|
|
CA2605697A1
(en)
*
|
2005-04-26 |
2006-11-02 |
Bioren, Inc. |
Method of producing human igg antibodies with enhanced effector functions
|
|
KR20080068004A
(ko)
*
|
2005-08-15 |
2008-07-22 |
아라나 테라퓨틱스 리미티드 |
뉴 월드 영장류 구조형성영역을 가진 조작 항체
|
|
JP2009515516A
(ja)
*
|
2005-11-14 |
2009-04-16 |
バイオレン・インク |
推定成熟ｃｄｒのブラスティングならびにコホートライブラリの作製およびスクリーニングによる抗体の超ヒト化
|
|
WO2007086994A1
(en)
*
|
2005-11-15 |
2007-08-02 |
Balyasnikova Irina V |
Single chain fragment of monoclonal antibody 9b9 and uses thereof
|
|
CA2634080A1
(en)
|
2005-12-20 |
2007-06-28 |
Arana Therapeutics Limited |
Anti-inflammatory dab
|
|
CN101400703B
(zh)
|
2006-02-01 |
2013-05-08 |
赛法隆澳大利亚控股有限公司 |
结构域抗体构建体
|
|
US7704953B2
(en)
*
|
2006-02-17 |
2010-04-27 |
Mdrna, Inc. |
Phage displayed cell binding peptides
|
|
WO2007112054A2
(en)
*
|
2006-03-23 |
2007-10-04 |
Sea Lane Biotechnologies, Llc |
Facilitation of translocation of molecules through the gastrointestinal tract
|
|
EP2024393A2
(en)
|
2006-05-15 |
2009-02-18 |
Sea Lane Biotechnologies,llc. |
Neutralizing antibodies to influenza viruses
|
|
WO2007136840A2
(en)
*
|
2006-05-20 |
2007-11-29 |
Codon Devices, Inc. |
Nucleic acid library design and assembly
|
|
EP2057191A1
(en)
|
2006-08-18 |
2009-05-13 |
Ablynx N.V. |
Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling
|
|
EP2069558B1
(en)
*
|
2006-10-02 |
2013-05-01 |
Sea Lane Biotechnologies,llc. |
Design and construction of diverse synthetic peptide and polypeptide libraries
|
|
US20080287320A1
(en)
*
|
2006-10-04 |
2008-11-20 |
Codon Devices |
Libraries and their design and assembly
|
|
KR20100028031A
(ko)
*
|
2007-06-06 |
2010-03-11 |
다니스코 유에스 인크. |
단백질 특성의 개선 방법
|
|
WO2009009045A2
(en)
*
|
2007-07-10 |
2009-01-15 |
The Scripps Research Institute |
Escape libraries of target polypeptides
|
|
US8680019B2
(en)
*
|
2007-08-10 |
2014-03-25 |
Protelica, Inc. |
Universal fibronectin Type III binding-domain libraries
|
|
US8470966B2
(en)
|
2007-08-10 |
2013-06-25 |
Protelica, Inc. |
Universal fibronectin type III binding-domain libraries
|
|
US20090176654A1
(en)
*
|
2007-08-10 |
2009-07-09 |
Protelix, Inc. |
Universal fibronectin type III binding-domain libraries
|
|
EP2220120A2
(en)
|
2007-11-27 |
2010-08-25 |
Ablynx N.V. |
Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
|
|
WO2009121004A2
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to viral antigens
|
|
EP2131245A3
(en)
*
|
2008-06-02 |
2012-08-01 |
ASML Netherlands BV |
Lithographic apparatus and its focus determination method
|
|
WO2010115995A2
(en)
|
2009-04-10 |
2010-10-14 |
Ablynx Nv |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
|
NZ595461A
(en)
|
2009-04-10 |
2013-01-25 |
Ablynx Nv |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
|
ES2643034T3
(es)
|
2009-06-05 |
2017-11-21 |
Ablynx N.V. |
Construcciones de Nanobody contra el virus respiratorio sincicial humano (VRSH) trivalentes para la prevención y/o el tratamiento de infecciones de las vías respiratorias
|
|
ES2652340T3
(es)
*
|
2009-07-17 |
2018-02-01 |
Bioatla Llc |
Selección y evolución simultáneas e integradas de rendimiento y expresión de proteínas humanas en huéspedes de producción
|
|
GB0914691D0
(en)
*
|
2009-08-21 |
2009-09-30 |
Lonza Biologics Plc |
Immunoglobulin variants
|
|
EP2494046B1
(en)
|
2009-10-30 |
2018-09-12 |
Novartis AG |
Universal fibronectin type iii bottom-side binding domain libraries
|
|
WO2011064382A1
(en)
|
2009-11-30 |
2011-06-03 |
Ablynx N.V. |
Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
|
|
CN107903321A
(zh)
|
2010-07-30 |
2018-04-13 |
诺华有限公司 |
纤连蛋白摇篮分子和其库
|
|
EP2647704B1
(en)
|
2010-12-01 |
2017-11-01 |
Mitsubishi Tanabe Pharma Corporation |
Polynucleotide construct capable of presenting fab in acellular translation system, and method for manufacturing and screening fab using same
|
|
US10138302B2
(en)
|
2011-09-23 |
2018-11-27 |
Ablynx N.V. |
Methods for treating rheumatoid arthritis by administering interleukin-6 receptor antibodies
|
|
SG11201404532XA
(en)
|
2012-03-02 |
2014-08-28 |
Ablynx Nv |
Pseudomonas aeruginosa pcrv binding single variable domain antibodies
|
|
US9777055B2
(en)
*
|
2012-04-20 |
2017-10-03 |
Thomas Jefferson University |
Engineered antibody for inhibition of fibrosis
|
|
NZ725398A
(en)
*
|
2012-05-25 |
2018-05-25 |
Chr Hansen As |
Variants of chymosin with improved milk-clotting properties
|
|
WO2014087010A1
(en)
|
2012-12-07 |
2014-06-12 |
Ablynx N.V. |
IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
|
|
KR101600899B1
(ko)
*
|
2012-12-11 |
2016-03-09 |
주식회사 셀레믹스 |
초병렬적 핵산 합성법을 통한 dna 라이브러리의 동시 합성 방법
|
|
US20140314741A1
(en)
*
|
2013-04-18 |
2014-10-23 |
Developmen Center For Biotechnology |
Human Antibody against Interleukin-20 and Treatment for Inflammatory Diseases
|
|
US9416197B2
(en)
|
2013-11-01 |
2016-08-16 |
Ibc Pharmaceuticals, Inc. |
Bispecific antibodies that neutralize both TNF-α and IL-6: novel therapeutic agent for autoimmune disease
|
|
CN104805507B
(zh)
*
|
2014-01-29 |
2019-01-22 |
杭州康万达医药科技有限公司 |
噬菌体展示文库及其应用和制备方法
|
|
RU2739004C1
(ru)
|
2014-02-26 |
2020-12-21 |
Кхр. Хансен А/С |
Варианты химозина с улучшенными молокосвертывающими свойствами
|
|
CA2963712A1
(en)
|
2014-10-21 |
2016-04-28 |
Ablynx Nv |
Treatment of il-6r related diseases
|
|
WO2016207214A1
(en)
|
2015-06-22 |
2016-12-29 |
Chr. Hansen A/S |
Variants of chymosin with improved properties
|
|
MX2018002366A
(es)
|
2015-08-31 |
2018-04-11 |
Chr Hansen As |
Variantes de quimosina con propiedades mejoradas.
|
|
IL260185B
(en)
*
|
2016-01-08 |
2022-09-01 |
Momotaro Gene Inc |
A combination therapy using reic/dkk-3 gene and a checkpoint inhibitor
|
|
CA3024211A1
(en)
|
2016-05-19 |
2017-11-23 |
Chr. Hansen A/S |
Variants of chymosin with improved milk-clotting properties
|
|
JP7395251B2
(ja)
|
2016-05-19 |
2023-12-11 |
セーホーエル．ハンセン アクティーゼルスカブ |
改善された凝乳特性を有するキモシン変異体
|
|
EP4282969A3
(en)
|
2016-09-02 |
2024-01-31 |
Lentigen Technology, Inc. |
Compositions and methods for treating cancer with duocars
|
|
MX2020006297A
(es)
|
2017-12-15 |
2020-12-07 |
Aleta Biotherapeutics Inc |
Variantes de cd19.
|